survival

You have access
Prognostic Value and Therapeutic Implications of Pleural Carcinosis and Malignant Pleural Effusion in Advanced Epithelial Ovarian Cancer
SARA NASSER, CHRISTINA FOTOPOULOU, ROLF RICHTER, JANA KAULICH, ELENA BRAICU, CARMEN BETETA, JESSICA OLSCHEWSKI, AYGUN BABAYEVA and JALID SEHOULI

Anticancer Research April 2021, 41 (4) 2033-2038; DOI: https://doi.org/10.21873/anticanres.14971
You have access
Prognostic Factors and Survival Score for Patients With Anaplastic Thyroid Carcinoma: A Retrospective Study from a Regional Registry
CHARLES MARCHAND-CRETY, MADELINE PASCARD, ADELINE DEBREUVE-THERESETTE, LEILA ETTALHAOUI, CLAIRE SCHVARTZ, MOHAMAD ZALZALI, MATHIAS BRUGEL, SARA BELLEFQIH and STÉPHANIE SERVAGI-VERNAT

Anticancer Research March 2021, 41 (3) 1555-1561; DOI: https://doi.org/10.21873/anticanres.14915
You have access
Immunohistochemical Assessment of TNFAIP3/A20 Expression Correlates With Early Tumorigenesis in Breast Cancer
FATEMEH SAHEB SHARIF-ASKARI, NOURA AL-KHAYYAL, IMAN TALAAT, NARJES SAHEB SHARIF-ASKARI, SURENDRA RAWAT, MAJD JUNDI, KARI SYRJÄNEN, RIFAT HAMOUDI and RIYAD BENDARDAF

Anticancer Research February 2021, 41 (2) 739-745; DOI: https://doi.org/10.21873/anticanres.14825
You have access
Metformin Associates With Aggressive Features of Endometrial Cancer in Women With Type 2 Diabetes
ELINA URPILAINEN, REETTA ARIMA, PEETER KARIHTALA, ULLA PUISTOLA and ANNE AHTIKOSKI

Anticancer Research February 2021, 41 (2) 821-828; DOI: https://doi.org/10.21873/anticanres.14834
You have access
Survival and Prognostic Nomogram for Primary Gastrointestinal Melanoma (PGIM): A Population-based Study
HARUN BADAKHSHI, ZI-MING WANG, REN-JIE LI, MAHMOUD ISMAIL and DAVID KAUL

Anticancer Research February 2021, 41 (2) 967-974; DOI: https://doi.org/10.21873/anticanres.14850
You have access
Epidermal Growth Factor Receptor and its Oncogenic EGFRvIII Variant in Benign and Malignant Brain Tumors
MICHAL KIELBUS, RADOSLAW ROLA, BOZENA JAROSZ, WITOLD JELENIEWICZ, MAREK CYBULSKI, AGNIESZKA STENZEL-BEMBENEK, ARKADIUSZ PODKOWINSKI, JOLANTA SMOK-KALWAT, KRZYSZTOF POLBERG, TOMASZ TROJANOWSKI, DAWID STEFANIUK and ANDRZEJ STEPULAK

Anticancer Research February 2021, 41 (2) 983-991; DOI: https://doi.org/10.21873/anticanres.14852
You have access
Prognostic Factors of Local Control and Survival in Patients Irradiated for Glioblastoma Multiforme (GBM)
JASPAR WITTELER, STEVEN E. SCHILD and DIRK RADES

Anticancer Research December 2020, 40 (12) 7025-7030; DOI: https://doi.org/10.21873/anticanres.14728
You have access
Re-Irradiation for Recurrent Glioblastoma Multiforme
DIRK RADES, JASPAR WITTELER, JAN LEPPERT and STEVEN E. SCHILD

Anticancer Research December 2020, 40 (12) 7077-7081; DOI: https://doi.org/10.21873/anticanres.14735
You have access
Stage III and Metastatic Lymph Node Ratio Are the only Independent Prognostic Factors in Colorectal Signet-ring Cell Carcinoma Patients
ALFREDO ANNICCHIARICO, ANDREA MORINI, ANDREA ROMBOLI, MATTEO RICCÒ, FRANCESCO LEONARDI, PELLEGRINO CRAFA, EDOARDO VIRGILIO, PAOLO DELL’ABATE and RENATO COSTI

Anticancer Research December 2020, 40 (12) 7127-7134; DOI: https://doi.org/10.21873/anticanres.14742
You have access
Re-Evaluation of Prognostic Factors for Survival After Radiotherapy of Cerebral Gliomas: A Supplementary Analysis to a Previous Study
JASPAR WITTELER, TROELS W. KJAER, SOEREN TVILSTED, STEVEN E. SCHILD and DIRK RADES

Anticancer Research November 2020, 40 (11) 6513-6515; DOI: https://doi.org/10.21873/anticanres.14674

Main menu

User menu

Search

survival

Pages